Purpose of this Study
We are doing this study to support vaccine development by studying blood cells of the immune system.
Who Can Participate?
Eligibility
Adults who:
<ul>
<li>Are ages 18 - 60</li>
<li>Are in good health</li>
<li>Do not have a bleeding disorder</li>
<li>Are at least 110 pounds</li>
<li>Do not have an autoimmune disease(s)</li>
<li>Are not pregnant</li>
<li>Have not had cancer within the past 5 years</li>
<li>Are not currently in an investigational study</li>
<li>Are not taking medications to treat high blood pressure</li></ul>
If you need assistance in understanding if you can participate, please contact Luis Ballón at 919-620-5334 or Darren Morrow at 919-684-6043.
<ul>
<li>Are ages 18 - 60</li>
<li>Are in good health</li>
<li>Do not have a bleeding disorder</li>
<li>Are at least 110 pounds</li>
<li>Do not have an autoimmune disease(s)</li>
<li>Are not pregnant</li>
<li>Have not had cancer within the past 5 years</li>
<li>Are not currently in an investigational study</li>
<li>Are not taking medications to treat high blood pressure</li></ul>
If you need assistance in understanding if you can participate, please contact Luis Ballón at 919-620-5334 or Darren Morrow at 919-684-6043.
What is Involved?
If you choose to join this study, you will have 2 visits.
<ul>
<li>You will have blood draws at both visits</li>
<li>The first visit will measure safety labs</li>
<li>The second visit will be 3 hours long for the leukapheresis procedure</li></ul>
<ul>
<li>You will have blood draws at both visits</li>
<li>The first visit will measure safety labs</li>
<li>The second visit will be 3 hours long for the leukapheresis procedure</li></ul>
Study Details
Full Title
EQA Proficiency Testing and Quality Control Leukapheresis Protocol
Principal Investigator
Thomas
Denny
Protocol Number
PRO00000873
Enrollment Status
Open to Enrollment